Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases (ESPOIR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01091311|
Recruitment Status : Completed
First Posted : March 24, 2010
Last Update Posted : June 8, 2011
Multicentric study, open label, uncontrolled phase IV in 30 patients with meibomian glands dysfunction .
Its objective is to Collect information from patients and ophthalmologists specialized in ocular surface and eyelids to anticipate how Blephasteam ® can be optimized.
This study involves 2 visits, visit of Inclusion, J0, then end of study visit, D21.
Between the two visits patients will be treated with Blephasteam ® for 21 days (up to two uses per day) and complete a questionnaire every two days during the first week and then once a week the next two weeks.
|Condition or disease||Intervention/treatment||Phase|
|Eyelid Diseases||Device: Blephasteam||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||30 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Phase IV Multicentric Study, 30 Patients Suffering of Meibomian Glands Dysfunction.|
|Study Start Date :||May 2010|
|Actual Primary Completion Date :||December 2010|
|Actual Study Completion Date :||December 2010|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01091311
|HÃ´pital Gabriel Montpied|
|Clermont-Ferrand, France, 63003|
|C.H.N.O des XV-XX|
|Paris, France, 75012|
|Hôpital Bichat - Claude Bernard|
|Paris, France, 75018|
|Principal Investigator:||Christophe Baudouin, Professor||Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts|
|Principal Investigator:||Frédéric Chiambaretta, Professor||Centre Hospitalier Universitaire de Clermont Ferrand|
|Principal Investigator:||Serge Doan, Doctor||Hopital Bichat|